BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23292493)

  • 41. Inhibition of breast cancer cell growth and invasiveness by dual silencing of HER-2 and VEGF.
    Tai W; Qin B; Cheng K
    Mol Pharm; 2010 Apr; 7(2):543-56. PubMed ID: 20047302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The critical role of HMGA2 in regulation of EMT in epithelial ovarian carcinomas.
    Yan J; Zhang Y; Shi W; Ren C; Liu Y; Pan Y
    Tumour Biol; 2016 Jan; 37(1):823-8. PubMed ID: 26250458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recombinant viral protein VP1 suppresses HER-2 expression and migration/metastasis of breast cancer.
    Hung SW; Chiu CF; Chen TA; Chu CL; Huang CC; Shyur LF; Liang CM; Liang SM
    Breast Cancer Res Treat; 2012 Nov; 136(1):89-105. PubMed ID: 22983836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo.
    Li L; Duan Z; Yu J; Dang HX
    Oncol Rep; 2016 Aug; 36(2):918-28. PubMed ID: 27350254
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Silencing of twist expression by RNA interference suppresses epithelial-mesenchymal transition, invasion, and metastasis of ovarian cancer.
    Wang WS; Yang XS; Xia M; Jiang HY; Hou JQ
    Asian Pac J Cancer Prev; 2012; 13(9):4435-9. PubMed ID: 23167357
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knockdown of astrocyte elevated gene-1 inhibited cell growth and induced apoptosis and suppressed invasion in ovarian cancer cells.
    Wang J; Chen X; Tong M
    Gene; 2017 Jun; 616():8-15. PubMed ID: 28323000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion.
    Wang FQ; Barfield E; Dutta S; Pua T; Fishman DA
    Gynecol Oncol; 2009 Dec; 115(3):414-23. PubMed ID: 19765808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreasing the ratio of matriptase/HAI‑1 by downregulation of matriptase as a potential adjuvant therapy in ovarian cancer.
    Sun P; Jiang Z; Chen X; Xue L; Mao X; Ruan G; Song Y; Mustea A
    Mol Med Rep; 2016 Aug; 14(2):1465-74. PubMed ID: 27356668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High expression of ENPP1 in high-grade serous ovarian carcinoma predicts poor prognosis and as a molecular therapy target.
    Wang H; Ye F; Zhou C; Cheng Q; Chen H
    PLoS One; 2021; 16(2):e0245733. PubMed ID: 33635867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors.
    Meng Y; Gu C; Wu Z; Zhao Y; Si Y; Fu X; Han W
    BMC Cancer; 2009 Mar; 9():75. PubMed ID: 19257909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin.
    Zhao L; Zhang P; Su XJ; Zhang B
    J Cell Physiol; 2018 Mar; 233(3):2420-2425. PubMed ID: 28771721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RASSF1A promotes apoptosis and suppresses the proliferation of ovarian cancer cells.
    Fu L; Zhang S
    Int J Mol Med; 2014 May; 33(5):1153-60. PubMed ID: 24573512
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppression of RNA interference on expression of c-myc of SKOV3 ovarian carcinoma cell line.
    Ai ZH; Wang J; Xu YL; Zhu XL; Teng YC
    Eur Rev Med Pharmacol Sci; 2013 Nov; 17(22):3002-6. PubMed ID: 24302178
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Biological effects of down-regulating of TIZ gene on ovarian cancer cells in vitro].
    Zhao BB; Zhang W; Yang ZJ; Wang Q; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2012 Oct; 47(10):781-6. PubMed ID: 23302738
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of WFDC 2 silencing on the proliferation, motility and invasion of human serous ovarian cancer cells in vitro.
    Zhu YF; Gao GL; Tang SB; Zhang ZD; Huang QS
    Asian Pac J Trop Med; 2013 Apr; 6(4):265-72. PubMed ID: 23608327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3.
    Yan Y; Jiang X; Zhao Y; Wen H; Liu G
    Cell Biochem Funct; 2015 Dec; 33(8):552-9. PubMed ID: 26526233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of sialidase NEU1 siRNA on proliferation, apoptosis, and invasion in human ovarian cancer.
    Ren LR; Zhang LP; Huang SY; Zhu YF; Li WJ; Fang SY; Shen L; Gao YL
    Mol Cell Biochem; 2016 Jan; 411(1-2):213-9. PubMed ID: 26463994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of MAPK7 in cell proliferation and metastasis in ovarian cancer.
    Dai J; Wang T; Wang W; Zhang S; Liao Y; Chen J
    Int J Clin Exp Pathol; 2015; 8(9):10444-51. PubMed ID: 26617753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coxsackie and adenovirus receptor is a critical regulator for the survival and growth of oral squamous carcinoma cells.
    Saito K; Sakaguchi M; Iioka H; Matsui M; Nakanishi H; Huh NH; Kondo E
    Oncogene; 2014 Mar; 33(10):1274-86. PubMed ID: 23503462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of siRNA targeting HER2/neu on the proliferation and viability of prostate cancer PC-3M cells.
    Liu CY; Xu PC; Chen DG; Fan XH; Li MQ; Yang X; Xu YP
    Genet Mol Res; 2015 Dec; 14(4):17145-53. PubMed ID: 26681061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.